Fat Grafting and the Palpable Breast Mass in Implant-Based Breast Reconstruction: Incidence and Implications.


Journal

Plastic and reconstructive surgery
ISSN: 1529-4242
Titre abrégé: Plast Reconstr Surg
Pays: United States
ID NLM: 1306050

Informations de publication

Date de publication:
08 2019
Historique:
entrez: 27 7 2019
pubmed: 28 7 2019
medline: 12 11 2019
Statut: ppublish

Résumé

Fat grafting is a powerful and increasingly used technique in breast reconstruction. However, fat necrosis can lead to palpable postoperative changes that can induce anxiety and lead to unplanned diagnostic studies. The authors' aim in this study was to evaluate the incidence, type, and timing of these unanticipated studies; the specialty of the ordering provider; and the factors that trigger the ordering process. A retrospective chart review was conducted for patients from 2006 to 2015 who underwent fat grafting as part of implant-based breast cancer reconstruction and had at least 1-year follow-up after fat grafting. From 2006 to 2015, 166 patients underwent fat grafting as part of implant-based breast reconstruction. Forty-four women (26.5 percent) underwent at least one imaging procedure. Thirteen women (7.8 percent) underwent 17 biopsies. For a palpable mass, the initial imaging test most commonly ordered was ultrasound, followed by mammography/ultrasound. The percentage of patients with a diagnosis of fat necrosis on mammography, ultrasound, and biopsy was 4.2, 12.7, and 5.4 percent, respectively. Seven patients (4.2 percent) had distant metastases. Tissue diagnosis of local recurrence was never identified. Mean follow-up was 2.4 years. Fat-grafting sequelae may lead to early unplanned invasive and noninvasive procedures initiated by a variety of providers. In this study, fat grafting had no impact on local recurrence rate. As use of fat grafting grows, communication among breast cancer care providers and enhanced patient and caregiver education will be increasingly important in optimizing the multidisciplinary evaluation and monitoring of palpable breast lesions. Therapeutic, IV.

Sections du résumé

BACKGROUND
Fat grafting is a powerful and increasingly used technique in breast reconstruction. However, fat necrosis can lead to palpable postoperative changes that can induce anxiety and lead to unplanned diagnostic studies. The authors' aim in this study was to evaluate the incidence, type, and timing of these unanticipated studies; the specialty of the ordering provider; and the factors that trigger the ordering process.
METHODS
A retrospective chart review was conducted for patients from 2006 to 2015 who underwent fat grafting as part of implant-based breast cancer reconstruction and had at least 1-year follow-up after fat grafting.
RESULTS
From 2006 to 2015, 166 patients underwent fat grafting as part of implant-based breast reconstruction. Forty-four women (26.5 percent) underwent at least one imaging procedure. Thirteen women (7.8 percent) underwent 17 biopsies. For a palpable mass, the initial imaging test most commonly ordered was ultrasound, followed by mammography/ultrasound. The percentage of patients with a diagnosis of fat necrosis on mammography, ultrasound, and biopsy was 4.2, 12.7, and 5.4 percent, respectively. Seven patients (4.2 percent) had distant metastases. Tissue diagnosis of local recurrence was never identified. Mean follow-up was 2.4 years.
CONCLUSIONS
Fat-grafting sequelae may lead to early unplanned invasive and noninvasive procedures initiated by a variety of providers. In this study, fat grafting had no impact on local recurrence rate. As use of fat grafting grows, communication among breast cancer care providers and enhanced patient and caregiver education will be increasingly important in optimizing the multidisciplinary evaluation and monitoring of palpable breast lesions.
CLINICAL QUESTION/LEVEL OF EVIDENCE
Therapeutic, IV.

Identifiants

pubmed: 31348325
doi: 10.1097/PRS.0000000000005790
pii: 00006534-201908000-00001
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

265-275

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Références

Kling RE, Mehrara BJ, Pusic AL, et al. Trends in autologous fat grafting to the breast: A national survey of the American Society of Plastic Surgeons. Plast Reconstr Surg. 2013;132:35–46.
Kasem A, Wazir U, Headon H, Mokbel K. Breast lipofilling: A review of current practice. Arch Plast Surg. 2015;42:126–130.
Kaoutzanis C, Xin M, Ballard TN, et al. Autologous fat grafting after breast reconstruction in postmastectomy patients: Complications, biopsy rates, and locoregional cancer recurrence rates. Ann Plast Surg. 2016;76:270–275.
D’Orsi CJ, Sickles EA, Mendelson EB, et al. ACR BI-RADS Atlas, Breast Imaging Reporting and Data System. 2013.Reston, Virginia: American College of Radiology.
Chan CW, McCulley SJ, Macmillan RD. Autologous fat transfer: A review of the literature with a focus on breast cancer surgery. J Plast Reconstr Aesthet Surg. 2008;61:1438–1448.
Niemelä SM, Miettinen S, Konttinen Y, et al. Fat tissue: Views on reconstruction and exploitation. J Craniofac Surg. 2007;18:325–335.
Boschert MT, Beckert BW, Puckett CL, Concannon MJ. Analysis of lipocyte viability after liposuction. Plast Reconstr Surg. 2002;109:761–765; discussion 766–767.
Peer LA. The neglected free fat graft, its behavior and clinical use. Am J Surg. 1956;92:40–47.
Veber M, Tourasse C, Toussoun G, Moutran M, Mojallal A, Delay E. Radiographic findings after breast augmentation by autologous fat transfer. Plast Reconstr Surg. 2011;127:1289–1299.
Gir P, Brown SA, Oni G, Kashefi N, Mojallal A, Rohrich RJ. Fat grafting: Evidence-based review on autologous fat harvesting, processing, reinjection, and storage. Plast Reconstr Surg. 2012;130:249–258.
Agostini T, Lazzeri D, Pini A, et al. Wet and dry techniques for structural fat graft harvesting: Histomorphometric and cell viability assessments of lipoaspirated samples. Plast Reconstr Surg. 2012;130:331e–339e.
Coleman SR. Facial recontouring with lipostructure. Clin Plast Surg. 1997;24:347–367.
Coleman SR, Saboeiro AP. Fat grafting to the breast revisited: Safety and efficacy. Plast Reconstr Surg. 2007;119:775–785; discussion 786–787.
Yu KD, Li S, Shao ZM. Different annual recurrence pattern between lumpectomy and mastectomy: Implication for breast cancer surveillance after breast-conserving surgery. Oncologist 2011;16:1101–1110.
Largo RD, Tchang LA, Mele V, et al. Efficacy, safety and complications of autologous fat grafting to healthy breast tissue: A systematic review. J Plast Reconstr Aesthet Surg. 2014;67:437–448.
De Decker M, De Schrijver L, Thiessen F, Tondu T, Van Goethem M, Tjalma WA. Breast cancer and fat grafting: Efficacy, safety and complications. A systematic review. Eur J Obstet Gynecol Reprod Biol. 2016;207:100–108.
Agha RA, Fowler AJ, Herlin C, Goodacre TE, Orgill DP. Use of autologous fat grafting for breast reconstruction: A systematic review with meta-analysis of oncological outcomes. J Plast Reconstr Aesthet Surg. 2015;68:143–161.
Spear SL, Coles CN, Leung BK, Gitlin M, Parekh M, Macarios D. The safety, effectiveness, and efficiency of autologous fat grafting in breast surgery. Plast Reconstr Surg Glob Open 2016;4:e827.
Groen JW, Negenborn VL, Twisk DJWR, et al. Autologous fat grafting in onco-plastic breast reconstruction: A systematic review on oncological and radiological safety, complications, volume retention and patient/surgeon satisfaction. J Plast Reconstr Aesthet Surg. 2016;69:742–764.
Dolen U, Cohen JB, Overschmidt B, Tenenbaum MM, Myckatyn TM. Fat grafting with tissue liquefaction technology as an adjunct to breast reconstruction. Aesthetic Plast Surg. 2016;40:854–862.
Hivernaud V, Lefourn B, Guicheux J, et al. Autologous fat grafting in the breast: Critical points and technique improvements. Aesthetic Plast Surg. 2015;39:547–561.
Krastev TK, Alshaikh GAH, Hommes J, Piatkowski A, van der Hulst RRWJ. Efficacy of autologous fat transfer for the correction of contour deformities in the breast: A systematic review and meta-analysis. J Plast Reconstr Aesthet Surg. 2018;71:1392–1409.
Garsa AA, Ferraro DJ, Dewees T, et al. Analysis of fat necrosis after adjuvant high-dose-rate interstitial brachytherapy for early stage breast cancer. Brachytherapy 2013;12:99–106.
Parikh RP, Doren EL, Mooney B, Sun WV, Laronga C, Smith PD. Differentiating fat necrosis from recurrent malignancy in fat-grafted breasts: An imaging classification system to guide management. Plast Reconstr Surg. 2012;130:761–772.
Pulagam SR, Poulton T, Mamounas EP. Long-term clinical and radiologic results with autologous fat transplantation for breast augmentation: Case reports and review of the literature. Breast J. 2006;12:63–65.
Costantini M, Cipriani A, Belli P, et al. Radiological findings in mammary autologous fat injections: A multi-technique evaluation. Clin Radiol. 2013;68:27–33.
Rigotti G, Marchi A, Galiè M, et al. Clinical treatment of radiotherapy tissue damage by lipoaspirate transplant: A healing process mediated by adipose-derived adult stem cells. Plast Reconstr Surg. 2007;119:1409–1422; discussion 1423–1424.
Coleman SR. Structural fat grafting: More than a permanent filler. Plast Reconstr Surg. 2006;118(Suppl):108S–120S.
Mestak O, Sukop A, Hsueh YS, et al. Centrifugation versus PureGraft for fatgrafting to the breast after breast-conserving therapy. World J Surg Oncol. 2014;12:178.
Millet E, Haik J, Ofir E, et al. The impact of autologous fat grafting on breast cancer: An experimental model using magnetic resonance imaging. Isr Med Assoc J. 2016;18:283–285.
Myckatyn TM, Wagner IJ, Mehrara BJ, et al. Cancer risk after fat transfer: A multicenter case-cohort study. Plast Reconstr Surg. 2017;139:11–18.

Auteurs

Rebecca W Knackstedt (RW)

From the Departments of Plastic Surgery and Radiology, Cleveland Clinic; and the Division of Plastic Surgery, MetroHealth.

James Gatherwright (J)

From the Departments of Plastic Surgery and Radiology, Cleveland Clinic; and the Division of Plastic Surgery, MetroHealth.

Dana Ataya (D)

From the Departments of Plastic Surgery and Radiology, Cleveland Clinic; and the Division of Plastic Surgery, MetroHealth.

Eliana F R Duraes (EFR)

From the Departments of Plastic Surgery and Radiology, Cleveland Clinic; and the Division of Plastic Surgery, MetroHealth.

Graham S Schwarz (GS)

From the Departments of Plastic Surgery and Radiology, Cleveland Clinic; and the Division of Plastic Surgery, MetroHealth.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH